nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—osteoarthritis—Methylprednisolone—systemic lupus erythematosus	0.219	0.5	CpDpCtD
Lidocaine—osteoarthritis—Prednisone—systemic lupus erythematosus	0.219	0.5	CpDpCtD
Lidocaine—CYP2C18—Dapsone—systemic lupus erythematosus	0.0489	0.123	CbGbCtD
Lidocaine—CYP2A6—Prednisolone—systemic lupus erythematosus	0.0174	0.0438	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Dapsone—systemic lupus erythematosus	0.0162	0.0408	CbGbCtD
Lidocaine—CYP3A7—Dapsone—systemic lupus erythematosus	0.0162	0.0408	CbGbCtD
Lidocaine—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0127	0.032	CbGbCtD
Lidocaine—CYP3A5—Dapsone—systemic lupus erythematosus	0.0122	0.0306	CbGbCtD
Lidocaine—CYP2C8—Dapsone—systemic lupus erythematosus	0.0117	0.0295	CbGbCtD
Lidocaine—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0115	0.0288	CbGbCtD
Lidocaine—CYP3A7—Hydrocortisone—systemic lupus erythematosus	0.0113	0.0284	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Hydrocortisone—systemic lupus erythematosus	0.0113	0.0284	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Cyclosporine—systemic lupus erythematosus	0.0107	0.0268	CbGbCtD
Lidocaine—CYP3A7—Cyclosporine—systemic lupus erythematosus	0.0107	0.0268	CbGbCtD
Lidocaine—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.0106	0.0266	CbGbCtD
Lidocaine—CYP2A6—Dexamethasone—systemic lupus erythematosus	0.0103	0.0259	CbGbCtD
Lidocaine—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0102	0.0255	CbGbCtD
Lidocaine—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.00907	0.0228	CbGbCtD
Lidocaine—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.00848	0.0213	CbGbCtD
Lidocaine—CYP2C9—Dapsone—systemic lupus erythematosus	0.00817	0.0205	CbGbCtD
Lidocaine—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.00815	0.0205	CbGbCtD
Lidocaine—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.008	0.0201	CbGbCtD
Lidocaine—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.0077	0.0194	CbGbCtD
Lidocaine—CYP3A7—Dexamethasone—systemic lupus erythematosus	0.00703	0.0177	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Dexamethasone—systemic lupus erythematosus	0.00703	0.0177	CbGbCtD
Lidocaine—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.00687	0.0173	CbGbCtD
Lidocaine—CYP2B6—Dexamethasone—systemic lupus erythematosus	0.00669	0.0168	CbGbCtD
Lidocaine—ABCB1—Betamethasone—systemic lupus erythematosus	0.0059	0.0148	CbGbCtD
Lidocaine—ABCB1—Prednisolone—systemic lupus erythematosus	0.00582	0.0146	CbGbCtD
Lidocaine—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00552	0.0139	CbGbCtD
Lidocaine—ABCB1—Prednisone—systemic lupus erythematosus	0.0055	0.0138	CbGbCtD
Lidocaine—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00543	0.0137	CbGbCtD
Lidocaine—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.00537	0.0135	CbGbCtD
Lidocaine—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.00527	0.0133	CbGbCtD
Lidocaine—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00521	0.0131	CbGbCtD
Lidocaine—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.00507	0.0127	CbGbCtD
Lidocaine—CYP2C9—cardial valve—systemic lupus erythematosus	0.00501	0.152	CbGeAlD
Lidocaine—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.00491	0.0123	CbGbCtD
Lidocaine—CYP3A4—Dapsone—systemic lupus erythematosus	0.00475	0.0119	CbGbCtD
Lidocaine—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00412	0.0104	CbGbCtD
Lidocaine—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00412	0.0104	CbGbCtD
Lidocaine—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00353	0.00889	CbGbCtD
Lidocaine—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00353	0.00889	CbGbCtD
Lidocaine—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00349	0.00877	CbGbCtD
Lidocaine—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00343	0.00863	CbGbCtD
Lidocaine—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00331	0.00831	CbGbCtD
Lidocaine—CYP3A4—Prednisone—systemic lupus erythematosus	0.00329	0.00828	CbGbCtD
Lidocaine—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00323	0.00813	CbGbCtD
Lidocaine—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00312	0.00785	CbGbCtD
Lidocaine—ABCB1—Methotrexate—systemic lupus erythematosus	0.00276	0.00693	CbGbCtD
Lidocaine—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00206	0.00517	CbGbCtD
Lidocaine—CYP1A2—urine—systemic lupus erythematosus	0.00114	0.0346	CbGeAlD
Lidocaine—CYP2C9—urine—systemic lupus erythematosus	0.00108	0.0328	CbGeAlD
Lidocaine—SCN9A—nephron tubule—systemic lupus erythematosus	0.00084	0.0256	CbGeAlD
Lidocaine—CYP3A4—urine—systemic lupus erythematosus	0.000823	0.025	CbGeAlD
Lidocaine—CYP2D6—urine—systemic lupus erythematosus	0.00081	0.0246	CbGeAlD
Lidocaine—CYP3A7-CYP3A51P—nephron tubule—systemic lupus erythematosus	0.000713	0.0217	CbGeAlD
Lidocaine—SCN4A—kidney—systemic lupus erythematosus	0.000659	0.02	CbGeAlD
Lidocaine—SCN10A—nephron tubule—systemic lupus erythematosus	0.00064	0.0195	CbGeAlD
Lidocaine—EGFR—lung—systemic lupus erythematosus	0.000636	0.0193	CbGeAlD
Lidocaine—CYP2C8—blood plasma—systemic lupus erythematosus	0.000634	0.0193	CbGeAlD
Lidocaine—CYP3A7-CYP3A51P—cortex of kidney—systemic lupus erythematosus	0.000611	0.0186	CbGeAlD
Lidocaine—SCN9A—tendon—systemic lupus erythematosus	0.000596	0.0181	CbGeAlD
Lidocaine—CYP1A2—blood plasma—systemic lupus erythematosus	0.000594	0.0181	CbGeAlD
Lidocaine—CYP3A5—blood plasma—systemic lupus erythematosus	0.000573	0.0174	CbGeAlD
Lidocaine—CYP2B6—blood plasma—systemic lupus erythematosus	0.000569	0.0173	CbGeAlD
Lidocaine—SCN2A—cortex of kidney—systemic lupus erythematosus	0.000568	0.0173	CbGeAlD
Lidocaine—CYP2C9—blood plasma—systemic lupus erythematosus	0.000563	0.0171	CbGeAlD
Lidocaine—SCN4A—tendon—systemic lupus erythematosus	0.000532	0.0162	CbGeAlD
Lidocaine—SCN9A—lung—systemic lupus erythematosus	0.000523	0.0159	CbGeAlD
Lidocaine—SCN3A—kidney—systemic lupus erythematosus	0.000513	0.0156	CbGeAlD
Lidocaine—SCN3A—cortex of kidney—systemic lupus erythematosus	0.000499	0.0152	CbGeAlD
Lidocaine—SCN10A—lymphoid tissue—systemic lupus erythematosus	0.000483	0.0147	CbGeAlD
Lidocaine—SCN4A—nervous system—systemic lupus erythematosus	0.000432	0.0132	CbGeAlD
Lidocaine—CYP3A4—blood plasma—systemic lupus erythematosus	0.00043	0.0131	CbGeAlD
Lidocaine—CYP2D6—blood plasma—systemic lupus erythematosus	0.000423	0.0129	CbGeAlD
Lidocaine—SCN4A—central nervous system—systemic lupus erythematosus	0.000416	0.0127	CbGeAlD
Lidocaine—SCN3A—tendon—systemic lupus erythematosus	0.000414	0.0126	CbGeAlD
Lidocaine—SCN3A—bone marrow—systemic lupus erythematosus	0.000401	0.0122	CbGeAlD
Lidocaine—SCN10A—lung—systemic lupus erythematosus	0.000398	0.0121	CbGeAlD
Lidocaine—SCN2A—nervous system—systemic lupus erythematosus	0.000383	0.0116	CbGeAlD
Lidocaine—SCN10A—nervous system—systemic lupus erythematosus	0.000369	0.0112	CbGeAlD
Lidocaine—SCN2A—central nervous system—systemic lupus erythematosus	0.000368	0.0112	CbGeAlD
Lidocaine—SCN3A—lung—systemic lupus erythematosus	0.000363	0.011	CbGeAlD
Lidocaine—CYP2A6—lung—systemic lupus erythematosus	0.000363	0.011	CbGeAlD
Lidocaine—SCN10A—central nervous system—systemic lupus erythematosus	0.000355	0.0108	CbGeAlD
Lidocaine—SLC22A5—nephron tubule—systemic lupus erythematosus	0.000338	0.0103	CbGeAlD
Lidocaine—SCN3A—nervous system—systemic lupus erythematosus	0.000336	0.0102	CbGeAlD
Lidocaine—SCN5A—nervous system—systemic lupus erythematosus	0.000335	0.0102	CbGeAlD
Lidocaine—SCN3A—central nervous system—systemic lupus erythematosus	0.000324	0.00985	CbGeAlD
Lidocaine—SCN5A—central nervous system—systemic lupus erythematosus	0.000323	0.00982	CbGeAlD
Lidocaine—SLC22A5—skin of body—systemic lupus erythematosus	0.000315	0.00958	CbGeAlD
Lidocaine—ABCB1—blood plasma—systemic lupus erythematosus	0.000304	0.00925	CbGeAlD
Lidocaine—SLC22A5—kidney—systemic lupus erythematosus	0.000297	0.00903	CbGeAlD
Lidocaine—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000295	0.00898	CbGeAlD
Lidocaine—CYP2B6—nephron tubule—systemic lupus erythematosus	0.000293	0.00893	CbGeAlD
Lidocaine—SLC22A5—cortex of kidney—systemic lupus erythematosus	0.000289	0.0088	CbGeAlD
Lidocaine—CYP2C8—kidney—systemic lupus erythematosus	0.000288	0.00875	CbGeAlD
Lidocaine—CYP2B6—skin of body—systemic lupus erythematosus	0.000274	0.00832	CbGeAlD
Lidocaine—CYP3A5—kidney—systemic lupus erythematosus	0.000259	0.00789	CbGeAlD
Lidocaine—CYP2B6—kidney—systemic lupus erythematosus	0.000258	0.00785	CbGeAlD
Lidocaine—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000253	0.00769	CbGeAlD
Lidocaine—SLC22A5—tendon—systemic lupus erythematosus	0.00024	0.00729	CbGeAlD
Lidocaine—CYP2B6—lymphoid tissue—systemic lupus erythematosus	0.000222	0.00674	CbGeAlD
Lidocaine—SLC22A5—lung—systemic lupus erythematosus	0.00021	0.0064	CbGeAlD
Lidocaine—CYP3A4—kidney—systemic lupus erythematosus	0.000195	0.00592	CbGeAlD
Lidocaine—CYP2D6—kidney—systemic lupus erythematosus	0.000192	0.00583	CbGeAlD
Lidocaine—CYP1A2—lung—systemic lupus erythematosus	0.000191	0.0058	CbGeAlD
Lidocaine—CYP3A5—lung—systemic lupus erythematosus	0.000184	0.00559	CbGeAlD
Lidocaine—CYP2B6—lung—systemic lupus erythematosus	0.000183	0.00556	CbGeAlD
Lidocaine—CYP2B6—nervous system—systemic lupus erythematosus	0.000169	0.00515	CbGeAlD
Lidocaine—CYP2B6—central nervous system—systemic lupus erythematosus	0.000163	0.00496	CbGeAlD
Lidocaine—ABCB1—nephron tubule—systemic lupus erythematosus	0.000157	0.00477	CbGeAlD
Lidocaine—ABCB1—kidney—systemic lupus erythematosus	0.000138	0.00419	CbGeAlD
Lidocaine—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000134	0.00408	CbGeAlD
Lidocaine—CYP3A4—nervous system—systemic lupus erythematosus	0.000128	0.00389	CbGeAlD
Lidocaine—CYP2D6—nervous system—systemic lupus erythematosus	0.000126	0.00383	CbGeAlD
Lidocaine—CYP3A4—central nervous system—systemic lupus erythematosus	0.000123	0.00374	CbGeAlD
Lidocaine—CYP2D6—central nervous system—systemic lupus erythematosus	0.000121	0.00368	CbGeAlD
Lidocaine—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000118	0.0036	CbGeAlD
Lidocaine—ABCB1—bone marrow—systemic lupus erythematosus	0.000108	0.00328	CbGeAlD
Lidocaine—ABCB1—lung—systemic lupus erythematosus	9.77e-05	0.00297	CbGeAlD
Lidocaine—Asthma—Methotrexate—systemic lupus erythematosus	9.27e-05	0.000879	CcSEcCtD
Lidocaine—Angiopathy—Dexamethasone—systemic lupus erythematosus	9.25e-05	0.000877	CcSEcCtD
Lidocaine—Angiopathy—Betamethasone—systemic lupus erythematosus	9.25e-05	0.000877	CcSEcCtD
Lidocaine—Hyperhidrosis—Cyclosporine—systemic lupus erythematosus	9.22e-05	0.000874	CcSEcCtD
Lidocaine—Convulsion—Prednisolone—systemic lupus erythematosus	9.21e-05	0.000874	CcSEcCtD
Lidocaine—Hypertension—Prednisolone—systemic lupus erythematosus	9.18e-05	0.000871	CcSEcCtD
Lidocaine—Shock—Mycophenolate mofetil—systemic lupus erythematosus	9.15e-05	0.000868	CcSEcCtD
Lidocaine—Loss of consciousness—Hydrocortisone—systemic lupus erythematosus	9.13e-05	0.000866	CcSEcCtD
Lidocaine—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	9.12e-05	0.000865	CcSEcCtD
Lidocaine—Hypersensitivity—Leflunomide—systemic lupus erythematosus	9.1e-05	0.000863	CcSEcCtD
Lidocaine—ABCB1—nervous system—systemic lupus erythematosus	9.04e-05	0.00275	CbGeAlD
Lidocaine—Bradycardia—Prednisone—systemic lupus erythematosus	9.04e-05	0.000857	CcSEcCtD
Lidocaine—Convulsion—Hydrocortisone—systemic lupus erythematosus	9e-05	0.000853	CcSEcCtD
Lidocaine—Hyperhidrosis—Mycophenolate mofetil—systemic lupus erythematosus	8.99e-05	0.000853	CcSEcCtD
Lidocaine—Hypertension—Hydrocortisone—systemic lupus erythematosus	8.97e-05	0.00085	CcSEcCtD
Lidocaine—Angioedema—Triamcinolone—systemic lupus erythematosus	8.93e-05	0.000847	CcSEcCtD
Lidocaine—Haemoglobin—Prednisone—systemic lupus erythematosus	8.92e-05	0.000846	CcSEcCtD
Lidocaine—Angioedema—Methylprednisolone—systemic lupus erythematosus	8.91e-05	0.000846	CcSEcCtD
Lidocaine—Haemorrhage—Prednisone—systemic lupus erythematosus	8.88e-05	0.000842	CcSEcCtD
Lidocaine—Erythema—Dexamethasone—systemic lupus erythematosus	8.87e-05	0.000841	CcSEcCtD
Lidocaine—Erythema—Betamethasone—systemic lupus erythematosus	8.87e-05	0.000841	CcSEcCtD
Lidocaine—Asthenia—Leflunomide—systemic lupus erythematosus	8.87e-05	0.000841	CcSEcCtD
Lidocaine—Anxiety—Hydrocortisone—systemic lupus erythematosus	8.81e-05	0.000836	CcSEcCtD
Lidocaine—ABCB1—central nervous system—systemic lupus erythematosus	8.71e-05	0.00265	CbGeAlD
Lidocaine—Hypotension—Mycophenolate mofetil—systemic lupus erythematosus	8.69e-05	0.000824	CcSEcCtD
Lidocaine—Anaphylactic shock—Prednisolone—systemic lupus erythematosus	8.68e-05	0.000823	CcSEcCtD
Lidocaine—Oedema—Prednisolone—systemic lupus erythematosus	8.68e-05	0.000823	CcSEcCtD
Lidocaine—Dizziness—Azathioprine—systemic lupus erythematosus	8.65e-05	0.000821	CcSEcCtD
Lidocaine—Loss of consciousness—Triamcinolone—systemic lupus erythematosus	8.59e-05	0.000815	CcSEcCtD
Lidocaine—Loss of consciousness—Methylprednisolone—systemic lupus erythematosus	8.57e-05	0.000813	CcSEcCtD
Lidocaine—Paraesthesia—Cyclosporine—systemic lupus erythematosus	8.56e-05	0.000812	CcSEcCtD
Lidocaine—Shock—Prednisolone—systemic lupus erythematosus	8.54e-05	0.00081	CcSEcCtD
Lidocaine—Dyspnoea—Cyclosporine—systemic lupus erythematosus	8.5e-05	0.000806	CcSEcCtD
Lidocaine—Somnolence—Cyclosporine—systemic lupus erythematosus	8.48e-05	0.000804	CcSEcCtD
Lidocaine—Anaphylactic shock—Hydrocortisone—systemic lupus erythematosus	8.47e-05	0.000804	CcSEcCtD
Lidocaine—Oedema—Hydrocortisone—systemic lupus erythematosus	8.47e-05	0.000804	CcSEcCtD
Lidocaine—Convulsion—Triamcinolone—systemic lupus erythematosus	8.47e-05	0.000804	CcSEcCtD
Lidocaine—Convulsion—Methylprednisolone—systemic lupus erythematosus	8.45e-05	0.000802	CcSEcCtD
Lidocaine—Hypertension—Triamcinolone—systemic lupus erythematosus	8.44e-05	0.000801	CcSEcCtD
Lidocaine—Hypertension—Methylprednisolone—systemic lupus erythematosus	8.42e-05	0.000799	CcSEcCtD
Lidocaine—Hyperhidrosis—Prednisolone—systemic lupus erythematosus	8.39e-05	0.000796	CcSEcCtD
Lidocaine—Paraesthesia—Mycophenolate mofetil—systemic lupus erythematosus	8.35e-05	0.000792	CcSEcCtD
Lidocaine—Shock—Hydrocortisone—systemic lupus erythematosus	8.34e-05	0.000791	CcSEcCtD
Lidocaine—Vomiting—Azathioprine—systemic lupus erythematosus	8.32e-05	0.000789	CcSEcCtD
Lidocaine—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	8.31e-05	0.000788	CcSEcCtD
Lidocaine—Eye disorder—Prednisone—systemic lupus erythematosus	8.29e-05	0.000787	CcSEcCtD
Lidocaine—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	8.29e-05	0.000787	CcSEcCtD
Lidocaine—Anxiety—Methylprednisolone—systemic lupus erythematosus	8.28e-05	0.000785	CcSEcCtD
Lidocaine—Somnolence—Mycophenolate mofetil—systemic lupus erythematosus	8.27e-05	0.000784	CcSEcCtD
Lidocaine—Drowsiness—Methotrexate—systemic lupus erythematosus	8.26e-05	0.000784	CcSEcCtD
Lidocaine—Rash—Azathioprine—systemic lupus erythematosus	8.25e-05	0.000782	CcSEcCtD
Lidocaine—Dermatitis—Azathioprine—systemic lupus erythematosus	8.24e-05	0.000782	CcSEcCtD
Lidocaine—Flushing—Prednisone—systemic lupus erythematosus	8.24e-05	0.000781	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	8.23e-05	0.000781	CcSEcCtD
Lidocaine—Headache—Azathioprine—systemic lupus erythematosus	8.2e-05	0.000777	CcSEcCtD
Lidocaine—Hyperhidrosis—Hydrocortisone—systemic lupus erythematosus	8.19e-05	0.000777	CcSEcCtD
Lidocaine—Dizziness—Leflunomide—systemic lupus erythematosus	8.17e-05	0.000775	CcSEcCtD
Lidocaine—Pain—Cyclosporine—systemic lupus erythematosus	8.15e-05	0.000773	CcSEcCtD
Lidocaine—Angioedema—Dexamethasone—systemic lupus erythematosus	8.11e-05	0.000769	CcSEcCtD
Lidocaine—Angioedema—Betamethasone—systemic lupus erythematosus	8.11e-05	0.000769	CcSEcCtD
Lidocaine—Stomatitis—Methotrexate—systemic lupus erythematosus	8.05e-05	0.000764	CcSEcCtD
Lidocaine—Angiopathy—Prednisone—systemic lupus erythematosus	8.05e-05	0.000764	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	8.03e-05	0.000762	CcSEcCtD
Lidocaine—Confusional state—Methylprednisolone—systemic lupus erythematosus	8.03e-05	0.000761	CcSEcCtD
Lidocaine—Immune system disorder—Prednisone—systemic lupus erythematosus	8.02e-05	0.00076	CcSEcCtD
Lidocaine—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	7.98e-05	0.000757	CcSEcCtD
Lidocaine—Oedema—Triamcinolone—systemic lupus erythematosus	7.98e-05	0.000757	CcSEcCtD
Lidocaine—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	7.96e-05	0.000755	CcSEcCtD
Lidocaine—Pain—Mycophenolate mofetil—systemic lupus erythematosus	7.95e-05	0.000755	CcSEcCtD
Lidocaine—Hypotension—Hydrocortisone—systemic lupus erythematosus	7.92e-05	0.000751	CcSEcCtD
Lidocaine—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	7.86e-05	0.000745	CcSEcCtD
Lidocaine—Vomiting—Leflunomide—systemic lupus erythematosus	7.86e-05	0.000745	CcSEcCtD
Lidocaine—Shock—Triamcinolone—systemic lupus erythematosus	7.85e-05	0.000745	CcSEcCtD
Lidocaine—Shock—Methylprednisolone—systemic lupus erythematosus	7.83e-05	0.000743	CcSEcCtD
Lidocaine—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	7.81e-05	0.000741	CcSEcCtD
Lidocaine—Loss of consciousness—Betamethasone—systemic lupus erythematosus	7.8e-05	0.00074	CcSEcCtD
Lidocaine—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	7.8e-05	0.00074	CcSEcCtD
Lidocaine—Paraesthesia—Prednisolone—systemic lupus erythematosus	7.79e-05	0.000739	CcSEcCtD
Lidocaine—Rash—Leflunomide—systemic lupus erythematosus	7.79e-05	0.000739	CcSEcCtD
Lidocaine—Dermatitis—Leflunomide—systemic lupus erythematosus	7.78e-05	0.000738	CcSEcCtD
Lidocaine—Nausea—Azathioprine—systemic lupus erythematosus	7.77e-05	0.000737	CcSEcCtD
Lidocaine—Headache—Leflunomide—systemic lupus erythematosus	7.74e-05	0.000734	CcSEcCtD
Lidocaine—Erythema—Prednisone—systemic lupus erythematosus	7.73e-05	0.000733	CcSEcCtD
Lidocaine—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	7.71e-05	0.000732	CcSEcCtD
Lidocaine—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	7.7e-05	0.00073	CcSEcCtD
Lidocaine—Convulsion—Betamethasone—systemic lupus erythematosus	7.69e-05	0.000729	CcSEcCtD
Lidocaine—Convulsion—Dexamethasone—systemic lupus erythematosus	7.69e-05	0.000729	CcSEcCtD
Lidocaine—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	7.67e-05	0.000727	CcSEcCtD
Lidocaine—Hypertension—Betamethasone—systemic lupus erythematosus	7.66e-05	0.000726	CcSEcCtD
Lidocaine—Hypertension—Dexamethasone—systemic lupus erythematosus	7.66e-05	0.000726	CcSEcCtD
Lidocaine—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	7.61e-05	0.000722	CcSEcCtD
Lidocaine—Urticaria—Cyclosporine—systemic lupus erythematosus	7.58e-05	0.000719	CcSEcCtD
Lidocaine—Anxiety—Dexamethasone—systemic lupus erythematosus	7.53e-05	0.000714	CcSEcCtD
Lidocaine—Anxiety—Betamethasone—systemic lupus erythematosus	7.53e-05	0.000714	CcSEcCtD
Lidocaine—Haemoglobin—Methotrexate—systemic lupus erythematosus	7.46e-05	0.000707	CcSEcCtD
Lidocaine—Hypotension—Methylprednisolone—systemic lupus erythematosus	7.44e-05	0.000706	CcSEcCtD
Lidocaine—Pain—Prednisolone—systemic lupus erythematosus	7.42e-05	0.000704	CcSEcCtD
Lidocaine—Haemorrhage—Methotrexate—systemic lupus erythematosus	7.42e-05	0.000704	CcSEcCtD
Lidocaine—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	7.39e-05	0.000701	CcSEcCtD
Lidocaine—Nausea—Leflunomide—systemic lupus erythematosus	7.34e-05	0.000696	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	7.32e-05	0.000694	CcSEcCtD
Lidocaine—Vision blurred—Prednisone—systemic lupus erythematosus	7.28e-05	0.000691	CcSEcCtD
Lidocaine—Pain—Hydrocortisone—systemic lupus erythematosus	7.25e-05	0.000687	CcSEcCtD
Lidocaine—Oedema—Dexamethasone—systemic lupus erythematosus	7.24e-05	0.000687	CcSEcCtD
Lidocaine—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	7.24e-05	0.000687	CcSEcCtD
Lidocaine—Oedema—Betamethasone—systemic lupus erythematosus	7.24e-05	0.000687	CcSEcCtD
Lidocaine—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	7.24e-05	0.000687	CcSEcCtD
Lidocaine—Paraesthesia—Triamcinolone—systemic lupus erythematosus	7.17e-05	0.00068	CcSEcCtD
Lidocaine—Feeling abnormal—Prednisolone—systemic lupus erythematosus	7.15e-05	0.000678	CcSEcCtD
Lidocaine—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	7.15e-05	0.000678	CcSEcCtD
Lidocaine—Visual impairment—Methotrexate—systemic lupus erythematosus	7.15e-05	0.000678	CcSEcCtD
Lidocaine—Shock—Dexamethasone—systemic lupus erythematosus	7.12e-05	0.000676	CcSEcCtD
Lidocaine—Shock—Betamethasone—systemic lupus erythematosus	7.12e-05	0.000676	CcSEcCtD
Lidocaine—Dyspnoea—Triamcinolone—systemic lupus erythematosus	7.11e-05	0.000675	CcSEcCtD
Lidocaine—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	7.1e-05	0.000673	CcSEcCtD
Lidocaine—Nervous system disorder—Betamethasone—systemic lupus erythematosus	7.1e-05	0.000673	CcSEcCtD
Lidocaine—Agitation—Prednisone—systemic lupus erythematosus	7.1e-05	0.000673	CcSEcCtD
Lidocaine—Angioedema—Prednisone—systemic lupus erythematosus	7.06e-05	0.00067	CcSEcCtD
Lidocaine—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	7.03e-05	0.000666	CcSEcCtD
Lidocaine—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	7e-05	0.000664	CcSEcCtD
Lidocaine—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	7e-05	0.000664	CcSEcCtD
Lidocaine—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	6.98e-05	0.000662	CcSEcCtD
Lidocaine—Eye disorder—Methotrexate—systemic lupus erythematosus	6.93e-05	0.000657	CcSEcCtD
Lidocaine—Tinnitus—Methotrexate—systemic lupus erythematosus	6.92e-05	0.000656	CcSEcCtD
Lidocaine—Urticaria—Prednisolone—systemic lupus erythematosus	6.89e-05	0.000654	CcSEcCtD
Lidocaine—Cardiac disorder—Methotrexate—systemic lupus erythematosus	6.88e-05	0.000653	CcSEcCtD
Lidocaine—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	6.85e-05	0.00065	CcSEcCtD
Lidocaine—Asthenia—Cyclosporine—systemic lupus erythematosus	6.84e-05	0.000649	CcSEcCtD
Lidocaine—Pain—Triamcinolone—systemic lupus erythematosus	6.82e-05	0.000647	CcSEcCtD
Lidocaine—Loss of consciousness—Prednisone—systemic lupus erythematosus	6.79e-05	0.000644	CcSEcCtD
Lidocaine—Hypotension—Betamethasone—systemic lupus erythematosus	6.77e-05	0.000642	CcSEcCtD
Lidocaine—Hypotension—Dexamethasone—systemic lupus erythematosus	6.77e-05	0.000642	CcSEcCtD
Lidocaine—Urticaria—Hydrocortisone—systemic lupus erythematosus	6.73e-05	0.000639	CcSEcCtD
Lidocaine—Angiopathy—Methotrexate—systemic lupus erythematosus	6.73e-05	0.000638	CcSEcCtD
Lidocaine—Immune system disorder—Methotrexate—systemic lupus erythematosus	6.7e-05	0.000635	CcSEcCtD
Lidocaine—Convulsion—Prednisone—systemic lupus erythematosus	6.69e-05	0.000635	CcSEcCtD
Lidocaine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	6.67e-05	0.000633	CcSEcCtD
Lidocaine—Hypertension—Prednisone—systemic lupus erythematosus	6.67e-05	0.000633	CcSEcCtD
Lidocaine—Chills—Methotrexate—systemic lupus erythematosus	6.66e-05	0.000631	CcSEcCtD
Lidocaine—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	6.58e-05	0.000624	CcSEcCtD
Lidocaine—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	6.56e-05	0.000622	CcSEcCtD
Lidocaine—Anxiety—Prednisone—systemic lupus erythematosus	6.55e-05	0.000622	CcSEcCtD
Lidocaine—Paraesthesia—Betamethasone—systemic lupus erythematosus	6.5e-05	0.000617	CcSEcCtD
Lidocaine—Paraesthesia—Dexamethasone—systemic lupus erythematosus	6.5e-05	0.000617	CcSEcCtD
Lidocaine—Erythema—Methotrexate—systemic lupus erythematosus	6.46e-05	0.000612	CcSEcCtD
Lidocaine—Hypersensitivity—Prednisolone—systemic lupus erythematosus	6.39e-05	0.000606	CcSEcCtD
Lidocaine—Urticaria—Triamcinolone—systemic lupus erythematosus	6.34e-05	0.000601	CcSEcCtD
Lidocaine—Urticaria—Methylprednisolone—systemic lupus erythematosus	6.33e-05	0.0006	CcSEcCtD
Lidocaine—Dysgeusia—Methotrexate—systemic lupus erythematosus	6.32e-05	0.0006	CcSEcCtD
Lidocaine—Dizziness—Cyclosporine—systemic lupus erythematosus	6.31e-05	0.000598	CcSEcCtD
Lidocaine—Anaphylactic shock—Prednisone—systemic lupus erythematosus	6.31e-05	0.000598	CcSEcCtD
Lidocaine—Oedema—Prednisone—systemic lupus erythematosus	6.31e-05	0.000598	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	6.25e-05	0.000593	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	6.25e-05	0.000593	CcSEcCtD
Lidocaine—Back pain—Methotrexate—systemic lupus erythematosus	6.25e-05	0.000592	CcSEcCtD
Lidocaine—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	6.24e-05	0.000592	CcSEcCtD
Lidocaine—Shock—Prednisone—systemic lupus erythematosus	6.2e-05	0.000588	CcSEcCtD
Lidocaine—Pain—Dexamethasone—systemic lupus erythematosus	6.19e-05	0.000587	CcSEcCtD
Lidocaine—Pain—Betamethasone—systemic lupus erythematosus	6.19e-05	0.000587	CcSEcCtD
Lidocaine—Nervous system disorder—Prednisone—systemic lupus erythematosus	6.18e-05	0.000587	CcSEcCtD
Lidocaine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	6.15e-05	0.000583	CcSEcCtD
Lidocaine—Hyperhidrosis—Prednisone—systemic lupus erythematosus	6.1e-05	0.000578	CcSEcCtD
Lidocaine—Vision blurred—Methotrexate—systemic lupus erythematosus	6.09e-05	0.000577	CcSEcCtD
Lidocaine—Asthenia—Hydrocortisone—systemic lupus erythematosus	6.08e-05	0.000577	CcSEcCtD
Lidocaine—Vomiting—Cyclosporine—systemic lupus erythematosus	6.06e-05	0.000575	CcSEcCtD
Lidocaine—Rash—Cyclosporine—systemic lupus erythematosus	6.01e-05	0.00057	CcSEcCtD
Lidocaine—Dermatitis—Cyclosporine—systemic lupus erythematosus	6.01e-05	0.00057	CcSEcCtD
Lidocaine—Headache—Cyclosporine—systemic lupus erythematosus	5.97e-05	0.000567	CcSEcCtD
Lidocaine—Feeling abnormal—Betamethasone—systemic lupus erythematosus	5.97e-05	0.000566	CcSEcCtD
Lidocaine—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	5.97e-05	0.000566	CcSEcCtD
Lidocaine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	5.91e-05	0.000561	CcSEcCtD
Lidocaine—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	5.88e-05	0.000558	CcSEcCtD
Lidocaine—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	5.87e-05	0.000556	CcSEcCtD
Lidocaine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	5.87e-05	0.000556	CcSEcCtD
Lidocaine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	5.86e-05	0.000556	CcSEcCtD
Lidocaine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	5.83e-05	0.000553	CcSEcCtD
Lidocaine—Urticaria—Dexamethasone—systemic lupus erythematosus	5.75e-05	0.000546	CcSEcCtD
Lidocaine—Urticaria—Betamethasone—systemic lupus erythematosus	5.75e-05	0.000546	CcSEcCtD
Lidocaine—Dizziness—Prednisolone—systemic lupus erythematosus	5.74e-05	0.000544	CcSEcCtD
Lidocaine—Asthenia—Triamcinolone—systemic lupus erythematosus	5.73e-05	0.000543	CcSEcCtD
Lidocaine—Asthenia—Methylprednisolone—systemic lupus erythematosus	5.71e-05	0.000542	CcSEcCtD
Lidocaine—Nausea—Cyclosporine—systemic lupus erythematosus	5.66e-05	0.000537	CcSEcCtD
Lidocaine—Paraesthesia—Prednisone—systemic lupus erythematosus	5.66e-05	0.000537	CcSEcCtD
Lidocaine—Dizziness—Hydrocortisone—systemic lupus erythematosus	5.6e-05	0.000532	CcSEcCtD
Lidocaine—Convulsion—Methotrexate—systemic lupus erythematosus	5.59e-05	0.000531	CcSEcCtD
Lidocaine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	5.53e-05	0.000524	CcSEcCtD
Lidocaine—Chest pain—Methotrexate—systemic lupus erythematosus	5.5e-05	0.000521	CcSEcCtD
Lidocaine—Rash—Prednisolone—systemic lupus erythematosus	5.47e-05	0.000519	CcSEcCtD
Lidocaine—Dermatitis—Prednisolone—systemic lupus erythematosus	5.47e-05	0.000518	CcSEcCtD
Lidocaine—Headache—Prednisolone—systemic lupus erythematosus	5.44e-05	0.000516	CcSEcCtD
Lidocaine—Vomiting—Hydrocortisone—systemic lupus erythematosus	5.39e-05	0.000511	CcSEcCtD
Lidocaine—Rash—Hydrocortisone—systemic lupus erythematosus	5.34e-05	0.000507	CcSEcCtD
Lidocaine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	5.34e-05	0.000506	CcSEcCtD
Lidocaine—Confusional state—Methotrexate—systemic lupus erythematosus	5.31e-05	0.000504	CcSEcCtD
Lidocaine—Headache—Hydrocortisone—systemic lupus erythematosus	5.31e-05	0.000504	CcSEcCtD
Lidocaine—Dizziness—Triamcinolone—systemic lupus erythematosus	5.28e-05	0.000501	CcSEcCtD
Lidocaine—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	5.27e-05	0.0005	CcSEcCtD
Lidocaine—Dizziness—Methylprednisolone—systemic lupus erythematosus	5.27e-05	0.000499	CcSEcCtD
Lidocaine—Feeling abnormal—Prednisone—systemic lupus erythematosus	5.2e-05	0.000493	CcSEcCtD
Lidocaine—Asthenia—Dexamethasone—systemic lupus erythematosus	5.19e-05	0.000493	CcSEcCtD
Lidocaine—Asthenia—Betamethasone—systemic lupus erythematosus	5.19e-05	0.000493	CcSEcCtD
Lidocaine—Nervous system disorder—Methotrexate—systemic lupus erythematosus	5.17e-05	0.00049	CcSEcCtD
Lidocaine—Nausea—Prednisolone—systemic lupus erythematosus	5.15e-05	0.000489	CcSEcCtD
Lidocaine—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	5.09e-05	0.000483	CcSEcCtD
Lidocaine—Vomiting—Triamcinolone—systemic lupus erythematosus	5.07e-05	0.000481	CcSEcCtD
Lidocaine—Vomiting—Methylprednisolone—systemic lupus erythematosus	5.06e-05	0.00048	CcSEcCtD
Lidocaine—Nausea—Hydrocortisone—systemic lupus erythematosus	5.03e-05	0.000477	CcSEcCtD
Lidocaine—Rash—Triamcinolone—systemic lupus erythematosus	5.03e-05	0.000477	CcSEcCtD
Lidocaine—Dermatitis—Triamcinolone—systemic lupus erythematosus	5.03e-05	0.000477	CcSEcCtD
Lidocaine—Rash—Methylprednisolone—systemic lupus erythematosus	5.02e-05	0.000476	CcSEcCtD
Lidocaine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	5.02e-05	0.000476	CcSEcCtD
Lidocaine—Urticaria—Prednisone—systemic lupus erythematosus	5.01e-05	0.000475	CcSEcCtD
Lidocaine—Headache—Triamcinolone—systemic lupus erythematosus	5e-05	0.000474	CcSEcCtD
Lidocaine—Headache—Methylprednisolone—systemic lupus erythematosus	4.99e-05	0.000473	CcSEcCtD
Lidocaine—Hypotension—Methotrexate—systemic lupus erythematosus	4.92e-05	0.000467	CcSEcCtD
Lidocaine—Dizziness—Betamethasone—systemic lupus erythematosus	4.79e-05	0.000454	CcSEcCtD
Lidocaine—Dizziness—Dexamethasone—systemic lupus erythematosus	4.79e-05	0.000454	CcSEcCtD
Lidocaine—Nausea—Triamcinolone—systemic lupus erythematosus	4.74e-05	0.00045	CcSEcCtD
Lidocaine—Paraesthesia—Methotrexate—systemic lupus erythematosus	4.73e-05	0.000449	CcSEcCtD
Lidocaine—Nausea—Methylprednisolone—systemic lupus erythematosus	4.73e-05	0.000449	CcSEcCtD
Lidocaine—Dyspnoea—Methotrexate—systemic lupus erythematosus	4.7e-05	0.000446	CcSEcCtD
Lidocaine—Somnolence—Methotrexate—systemic lupus erythematosus	4.68e-05	0.000444	CcSEcCtD
Lidocaine—Hypersensitivity—Prednisone—systemic lupus erythematosus	4.65e-05	0.000441	CcSEcCtD
Lidocaine—Vomiting—Dexamethasone—systemic lupus erythematosus	4.6e-05	0.000437	CcSEcCtD
Lidocaine—Vomiting—Betamethasone—systemic lupus erythematosus	4.6e-05	0.000437	CcSEcCtD
Lidocaine—Rash—Betamethasone—systemic lupus erythematosus	4.57e-05	0.000433	CcSEcCtD
Lidocaine—Rash—Dexamethasone—systemic lupus erythematosus	4.57e-05	0.000433	CcSEcCtD
Lidocaine—Dermatitis—Betamethasone—systemic lupus erythematosus	4.56e-05	0.000433	CcSEcCtD
Lidocaine—Dermatitis—Dexamethasone—systemic lupus erythematosus	4.56e-05	0.000433	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	4.55e-05	0.000432	CcSEcCtD
Lidocaine—Headache—Dexamethasone—systemic lupus erythematosus	4.54e-05	0.00043	CcSEcCtD
Lidocaine—Headache—Betamethasone—systemic lupus erythematosus	4.54e-05	0.00043	CcSEcCtD
Lidocaine—Asthenia—Prednisone—systemic lupus erythematosus	4.52e-05	0.000429	CcSEcCtD
Lidocaine—Pain—Methotrexate—systemic lupus erythematosus	4.51e-05	0.000427	CcSEcCtD
Lidocaine—Feeling abnormal—Methotrexate—systemic lupus erythematosus	4.34e-05	0.000412	CcSEcCtD
Lidocaine—Nausea—Dexamethasone—systemic lupus erythematosus	4.3e-05	0.000408	CcSEcCtD
Lidocaine—Nausea—Betamethasone—systemic lupus erythematosus	4.3e-05	0.000408	CcSEcCtD
Lidocaine—Urticaria—Methotrexate—systemic lupus erythematosus	4.19e-05	0.000397	CcSEcCtD
Lidocaine—Dizziness—Prednisone—systemic lupus erythematosus	4.17e-05	0.000395	CcSEcCtD
Lidocaine—Vomiting—Prednisone—systemic lupus erythematosus	4.01e-05	0.00038	CcSEcCtD
Lidocaine—Rash—Prednisone—systemic lupus erythematosus	3.98e-05	0.000377	CcSEcCtD
Lidocaine—Dermatitis—Prednisone—systemic lupus erythematosus	3.97e-05	0.000377	CcSEcCtD
Lidocaine—Headache—Prednisone—systemic lupus erythematosus	3.95e-05	0.000375	CcSEcCtD
Lidocaine—Hypersensitivity—Methotrexate—systemic lupus erythematosus	3.88e-05	0.000368	CcSEcCtD
Lidocaine—Asthenia—Methotrexate—systemic lupus erythematosus	3.78e-05	0.000359	CcSEcCtD
Lidocaine—Nausea—Prednisone—systemic lupus erythematosus	3.75e-05	0.000355	CcSEcCtD
Lidocaine—Dizziness—Methotrexate—systemic lupus erythematosus	3.48e-05	0.000331	CcSEcCtD
Lidocaine—Vomiting—Methotrexate—systemic lupus erythematosus	3.35e-05	0.000318	CcSEcCtD
Lidocaine—Rash—Methotrexate—systemic lupus erythematosus	3.32e-05	0.000315	CcSEcCtD
Lidocaine—Dermatitis—Methotrexate—systemic lupus erythematosus	3.32e-05	0.000315	CcSEcCtD
Lidocaine—Headache—Methotrexate—systemic lupus erythematosus	3.3e-05	0.000313	CcSEcCtD
Lidocaine—Nausea—Methotrexate—systemic lupus erythematosus	3.13e-05	0.000297	CcSEcCtD
Lidocaine—EGFR—Adaptive Immune System—CD8A—systemic lupus erythematosus	1.22e-05	0.000463	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—IL6—systemic lupus erythematosus	1.22e-05	0.000462	CbGpPWpGaD
Lidocaine—EGFR—Immune System—FCGR2A—systemic lupus erythematosus	1.21e-05	0.000459	CbGpPWpGaD
Lidocaine—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	1.21e-05	0.000459	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—TNF—systemic lupus erythematosus	1.21e-05	0.000456	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—CDKN1B—systemic lupus erythematosus	1.21e-05	0.000456	CbGpPWpGaD
Lidocaine—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	1.2e-05	0.000453	CbGpPWpGaD
Lidocaine—EGFR—Immune System—TNFAIP3—systemic lupus erythematosus	1.19e-05	0.000451	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.19e-05	0.000449	CbGpPWpGaD
Lidocaine—EGFR—Immune System—BLK—systemic lupus erythematosus	1.18e-05	0.000445	CbGpPWpGaD
Lidocaine—EGFR—Disease—CD247—systemic lupus erythematosus	1.18e-05	0.000444	CbGpPWpGaD
Lidocaine—SLC22A5—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.17e-05	0.000443	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—IL6—systemic lupus erythematosus	1.17e-05	0.000442	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—IL6—systemic lupus erythematosus	1.15e-05	0.000435	CbGpPWpGaD
Lidocaine—EGFR—Disease—NCF2—systemic lupus erythematosus	1.14e-05	0.000432	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—C3—systemic lupus erythematosus	1.14e-05	0.000431	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—CDKN1A—systemic lupus erythematosus	1.11e-05	0.000421	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—MMP9—systemic lupus erythematosus	1.1e-05	0.000417	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—IL6—systemic lupus erythematosus	1.1e-05	0.000415	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—IL6—systemic lupus erythematosus	1.1e-05	0.000415	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—C3—systemic lupus erythematosus	1.09e-05	0.000413	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—IL6—systemic lupus erythematosus	1.09e-05	0.000413	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—IL6—systemic lupus erythematosus	1.09e-05	0.000411	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—NAT2—systemic lupus erythematosus	1.09e-05	0.000411	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—CXCL12—systemic lupus erythematosus	1.08e-05	0.00041	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CRP—systemic lupus erythematosus	1.08e-05	0.00041	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—IL6—systemic lupus erythematosus	1.08e-05	0.000409	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PTPRC—systemic lupus erythematosus	1.05e-05	0.000398	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—IL6—systemic lupus erythematosus	1.05e-05	0.000397	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL1RN—systemic lupus erythematosus	1.05e-05	0.000396	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—PPARG—systemic lupus erythematosus	1.05e-05	0.000395	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—EP300—systemic lupus erythematosus	1.04e-05	0.000395	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—TLR4—systemic lupus erythematosus	1.04e-05	0.000393	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—IL6—systemic lupus erythematosus	1.02e-05	0.000385	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—systemic lupus erythematosus	1.02e-05	0.000385	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—IL6—systemic lupus erythematosus	1.02e-05	0.000385	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—MMP9—systemic lupus erythematosus	1.01e-05	0.000382	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	1.01e-05	0.000382	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—IL6—systemic lupus erythematosus	1.01e-05	0.000382	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—IL6—systemic lupus erythematosus	1.01e-05	0.000382	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—IL6—systemic lupus erythematosus	1.01e-05	0.000382	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—IL6—systemic lupus erythematosus	1e-05	0.000378	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—NAT2—systemic lupus erythematosus	9.96e-06	0.000377	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—HLA-DRB1—systemic lupus erythematosus	9.96e-06	0.000377	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—IL6—systemic lupus erythematosus	9.96e-06	0.000377	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—VEGFA—systemic lupus erythematosus	9.89e-06	0.000374	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TLR9—systemic lupus erythematosus	9.82e-06	0.000371	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CD40—systemic lupus erythematosus	9.79e-06	0.00037	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—IL6—systemic lupus erythematosus	9.73e-06	0.000368	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CTLA4—systemic lupus erythematosus	9.65e-06	0.000365	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HMGB1—systemic lupus erythematosus	9.65e-06	0.000365	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—IL6—systemic lupus erythematosus	9.59e-06	0.000363	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CD80—systemic lupus erythematosus	9.58e-06	0.000362	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—P2RY12—systemic lupus erythematosus	9.51e-06	0.00036	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IFNA1—systemic lupus erythematosus	9.48e-06	0.000359	CbGpPWpGaD
Lidocaine—EGFR—Immune System—RASGRP1—systemic lupus erythematosus	9.23e-06	0.000349	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CD79A—systemic lupus erythematosus	9.2e-06	0.000348	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CD80—systemic lupus erythematosus	9.2e-06	0.000348	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—RXRA—systemic lupus erythematosus	9.17e-06	0.000347	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—TYK2—systemic lupus erythematosus	9.16e-06	0.000346	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—TGFB1—systemic lupus erythematosus	9.08e-06	0.000343	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—VEGFA—systemic lupus erythematosus	9.08e-06	0.000343	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—systemic lupus erythematosus	9.02e-06	0.000341	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	8.98e-06	0.00034	CbGpPWpGaD
Lidocaine—EGFR—Disease—JUNB—systemic lupus erythematosus	8.97e-06	0.000339	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PRL—systemic lupus erythematosus	8.95e-06	0.000339	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	8.88e-06	0.000336	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CSK—systemic lupus erythematosus	8.76e-06	0.000331	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	8.72e-06	0.00033	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	8.57e-06	0.000324	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HLA-DQA1—systemic lupus erythematosus	8.49e-06	0.000321	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—TNF—systemic lupus erythematosus	8.48e-06	0.000321	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	8.41e-06	0.000318	CbGpPWpGaD
Lidocaine—EGFR—Disease—PRL—systemic lupus erythematosus	8.27e-06	0.000313	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—TYK2—systemic lupus erythematosus	8.09e-06	0.000306	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—NAT2—systemic lupus erythematosus	8.04e-06	0.000304	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NCF2—systemic lupus erythematosus	8.01e-06	0.000303	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—LYN—systemic lupus erythematosus	7.95e-06	0.000301	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HLA-DQB1—systemic lupus erythematosus	7.95e-06	0.0003	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—NAT2—systemic lupus erythematosus	7.86e-06	0.000297	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—JAK1—systemic lupus erythematosus	7.84e-06	0.000296	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SH2B3—systemic lupus erythematosus	7.8e-06	0.000295	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	7.76e-06	0.000293	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL18—systemic lupus erythematosus	7.53e-06	0.000285	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CD40LG—systemic lupus erythematosus	7.5e-06	0.000284	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—CCR5—systemic lupus erythematosus	7.43e-06	0.000281	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CD8A—systemic lupus erythematosus	7.42e-06	0.000281	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	7.38e-06	0.000279	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—IL2RA—systemic lupus erythematosus	7.32e-06	0.000277	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CD4—systemic lupus erythematosus	7.32e-06	0.000277	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—C3—systemic lupus erythematosus	7.26e-06	0.000274	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—MMP9—systemic lupus erythematosus	7.21e-06	0.000273	CbGpPWpGaD
Lidocaine—EGFR—Immune System—JAK1—systemic lupus erythematosus	7.16e-06	0.000271	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	7.1e-06	0.000268	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CD4—systemic lupus erythematosus	7.03e-06	0.000266	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	6.99e-06	0.000264	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	6.97e-06	0.000264	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—IL6—systemic lupus erythematosus	6.94e-06	0.000262	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CDKN1B—systemic lupus erythematosus	6.88e-06	0.00026	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—IL6—systemic lupus erythematosus	6.84e-06	0.000259	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—EP300—systemic lupus erythematosus	6.84e-06	0.000259	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	6.81e-06	0.000257	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL2RA—systemic lupus erythematosus	6.69e-06	0.000253	CbGpPWpGaD
Lidocaine—EGFR—Immune System—C3—systemic lupus erythematosus	6.63e-06	0.000251	CbGpPWpGaD
Lidocaine—EGFR—Disease—JAK1—systemic lupus erythematosus	6.61e-06	0.00025	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CDKN1B—systemic lupus erythematosus	6.61e-06	0.00025	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—VEGFA—systemic lupus erythematosus	6.48e-06	0.000245	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	6.42e-06	0.000243	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CXCL12—systemic lupus erythematosus	6.4e-06	0.000242	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—F2—systemic lupus erythematosus	6.37e-06	0.000241	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CDKN1A—systemic lupus erythematosus	6.35e-06	0.00024	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CRP—systemic lupus erythematosus	6.31e-06	0.000239	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—JUNB—systemic lupus erythematosus	6.28e-06	0.000238	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—IL6—systemic lupus erythematosus	6.28e-06	0.000237	CbGpPWpGaD
Lidocaine—EGFR—Disease—CCR5—systemic lupus erythematosus	6.27e-06	0.000237	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CDKN1A—systemic lupus erythematosus	6.1e-06	0.00023	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—RXRA—systemic lupus erythematosus	6.09e-06	0.00023	CbGpPWpGaD
Lidocaine—EGFR—Immune System—TLR4—systemic lupus erythematosus	6.05e-06	0.000229	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HLA-DRB1—systemic lupus erythematosus	6.04e-06	0.000228	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—EP300—systemic lupus erythematosus	6.04e-06	0.000228	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	5.99e-06	0.000227	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—RASGRP1—systemic lupus erythematosus	5.97e-06	0.000226	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	5.96e-06	0.000225	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—TGFB1—systemic lupus erythematosus	5.95e-06	0.000225	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	5.93e-06	0.000224	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PRL—systemic lupus erythematosus	5.79e-06	0.000219	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PPARG—systemic lupus erythematosus	5.79e-06	0.000219	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—CCL2—systemic lupus erythematosus	5.68e-06	0.000215	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	5.59e-06	0.000211	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—RXRA—systemic lupus erythematosus	5.59e-06	0.000211	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CD80—systemic lupus erythematosus	5.58e-06	0.000211	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—TNF—systemic lupus erythematosus	5.55e-06	0.00021	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	5.54e-06	0.000209	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.41e-06	0.000205	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—ALB—systemic lupus erythematosus	5.2e-06	0.000197	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—TYK2—systemic lupus erythematosus	5.16e-06	0.000195	CbGpPWpGaD
Lidocaine—EGFR—Disease—CD80—systemic lupus erythematosus	5.15e-06	0.000195	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—NOS3—systemic lupus erythematosus	4.98e-06	0.000188	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.86e-06	0.000184	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	4.73e-06	0.000179	CbGpPWpGaD
Lidocaine—EGFR—Immune System—TYK2—systemic lupus erythematosus	4.71e-06	0.000178	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—JAK1—systemic lupus erythematosus	4.63e-06	0.000175	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PTGS2—systemic lupus erythematosus	4.55e-06	0.000172	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—RXRA—systemic lupus erythematosus	4.51e-06	0.00017	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—IL6—systemic lupus erythematosus	4.48e-06	0.000169	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IFNG—systemic lupus erythematosus	4.41e-06	0.000167	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—RXRA—systemic lupus erythematosus	4.4e-06	0.000167	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.4e-06	0.000166	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCR5—systemic lupus erythematosus	4.39e-06	0.000166	CbGpPWpGaD
Lidocaine—EGFR—Disease—TYK2—systemic lupus erythematosus	4.35e-06	0.000164	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.32e-06	0.000163	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—IL2—systemic lupus erythematosus	4.29e-06	0.000162	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—C3—systemic lupus erythematosus	4.29e-06	0.000162	CbGpPWpGaD
Lidocaine—EGFR—Disease—NOS3—systemic lupus erythematosus	4.27e-06	0.000161	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CD4—systemic lupus erythematosus	4.26e-06	0.000161	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.26e-06	0.000161	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	4.03e-06	0.000152	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CDKN1B—systemic lupus erythematosus	4.01e-06	0.000151	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.96e-06	0.00015	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—IL6—systemic lupus erythematosus	3.96e-06	0.00015	CbGpPWpGaD
Lidocaine—EGFR—Disease—CD4—systemic lupus erythematosus	3.93e-06	0.000149	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL2—systemic lupus erythematosus	3.92e-06	0.000148	CbGpPWpGaD
Lidocaine—EGFR—Disease—PTGS2—systemic lupus erythematosus	3.91e-06	0.000148	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PPARG—systemic lupus erythematosus	3.85e-06	0.000145	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	3.82e-06	0.000144	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—EP300—systemic lupus erythematosus	3.79e-06	0.000143	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—F2—systemic lupus erythematosus	3.76e-06	0.000142	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.76e-06	0.000142	CbGpPWpGaD
Lidocaine—EGFR—Disease—CDKN1B—systemic lupus erythematosus	3.7e-06	0.00014	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CDKN1A—systemic lupus erythematosus	3.7e-06	0.00014	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	3.65e-06	0.000138	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CD80—systemic lupus erythematosus	3.61e-06	0.000136	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.54e-06	0.000134	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PPARG—systemic lupus erythematosus	3.53e-06	0.000133	CbGpPWpGaD
Lidocaine—EGFR—Immune System—EP300—systemic lupus erythematosus	3.52e-06	0.000133	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.46e-06	0.000131	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ALB—systemic lupus erythematosus	3.46e-06	0.000131	CbGpPWpGaD
Lidocaine—EGFR—Disease—CDKN1A—systemic lupus erythematosus	3.41e-06	0.000129	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.38e-06	0.000128	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCL2—systemic lupus erythematosus	3.36e-06	0.000127	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	3.32e-06	0.000126	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—NOS3—systemic lupus erythematosus	3.31e-06	0.000125	CbGpPWpGaD
Lidocaine—EGFR—Disease—EP300—systemic lupus erythematosus	3.25e-06	0.000123	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ALB—systemic lupus erythematosus	3.17e-06	0.00012	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	3.13e-06	0.000118	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	3.11e-06	0.000117	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TYK2—systemic lupus erythematosus	3.05e-06	0.000115	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—NOS3—systemic lupus erythematosus	3.03e-06	0.000115	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTGS2—systemic lupus erythematosus	3.03e-06	0.000114	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NOS3—systemic lupus erythematosus	2.99e-06	0.000113	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.96e-06	0.000112	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.88e-06	0.000109	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PPARG—systemic lupus erythematosus	2.85e-06	0.000108	CbGpPWpGaD
Lidocaine—EGFR—Disease—TGFB1—systemic lupus erythematosus	2.82e-06	0.000107	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	2.78e-06	0.000105	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTGS2—systemic lupus erythematosus	2.77e-06	0.000105	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	2.65e-06	0.0001	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.59e-06	9.79e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ALB—systemic lupus erythematosus	2.56e-06	9.67e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL2—systemic lupus erythematosus	2.54e-06	9.58e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—IL6—systemic lupus erythematosus	2.52e-06	9.54e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—EP300—systemic lupus erythematosus	2.52e-06	9.52e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	2.5e-06	9.46e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.46e-06	9.31e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—NOS3—systemic lupus erythematosus	2.45e-06	9.25e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	2.41e-06	9.11e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MMP9—systemic lupus erythematosus	2.4e-06	9.07e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	2.39e-06	9.04e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.39e-06	9.04e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—EP300—systemic lupus erythematosus	2.31e-06	8.72e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL6—systemic lupus erythematosus	2.3e-06	8.71e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—EP300—systemic lupus erythematosus	2.27e-06	8.6e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTGS2—systemic lupus erythematosus	2.24e-06	8.46e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	2.19e-06	8.27e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	2.17e-06	8.19e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.15e-06	8.15e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—IL6—systemic lupus erythematosus	2.13e-06	8.05e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	2.1e-06	7.94e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	2.07e-06	7.83e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	2.05e-06	7.74e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	1.98e-06	7.48e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.98e-06	7.48e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	1.96e-06	7.41e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	1.9e-06	7.17e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ALB—systemic lupus erythematosus	1.89e-06	7.14e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—EP300—systemic lupus erythematosus	1.86e-06	7.04e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	1.82e-06	6.88e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	1.81e-06	6.83e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	1.78e-06	6.72e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	1.76e-06	6.67e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	1.7e-06	6.43e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	1.69e-06	6.38e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	1.68e-06	6.33e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	1.65e-06	6.24e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	1.58e-06	5.96e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	1.56e-06	5.88e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	1.54e-06	5.83e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	1.51e-06	5.7e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL6—systemic lupus erythematosus	1.49e-06	5.63e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	1.44e-06	5.45e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—EP300—systemic lupus erythematosus	1.37e-06	5.19e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	1.32e-06	4.98e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	1.29e-06	4.89e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.29e-06	4.89e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	1.28e-06	4.85e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.16e-06	4.4e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.11e-06	4.2e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	1.1e-06	4.14e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.02e-06	3.85e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	8.46e-07	3.2e-05	CbGpPWpGaD
